|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsor: | National Center for Research Resources (NCRR) |
|---|---|
| Information provided by: | National Center for Research Resources (NCRR) |
| ClinicalTrials.gov Identifier: | NCT00013962 |
Purpose
The Williams syndrome is a disease in which supravalvular aortic stenosis, an elfin facies, mental retardation and other congenital defects are sometimes associated with abnormal vitamin D and calcium metabolism. Whereas some patients have been reported to show increased sensitivity to vitamin D or an exaggerated response of serum 25-hydroxyvitamin D {25(OH)D} to administration of vitamin D and to have hypercalcemia caused by increased circulating 1,25-dihydroxyvitamin D{1,25(OH)2D} in infancy and early childhood, most patients have normal calcium metabolism and normal values for circulating 25(OH)D and 1,25(OH)2D. We propose to carry out further studies of vitamin D metabolism to elucidate the mechanism(s) for abnormal vitamin D metabolism. We will determine the response of serum 1,25(OH)2D to administration of 1,25(OH)2D3. Measurement of the 1,25(OH)2D in the patients compared to normal subjects will be the primary outcome.
| Condition | Intervention |
|---|---|
|
Williams Syndrome |
Drug: Vitamin D |
| Study Type: | Observational |
| Study Design: | Observational Model: Case Control Observational Model: Natural History |
| Official Title: | Vitamin D Metabolism and the Williams Syndrome |
Eligibility| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Age 18 years to 50 years of age, patients and normal subjects
Contacts and Locations
More Information
| Study ID Numbers: | NCRR-M01RR01070-0562 |
| Study First Received: | April 3, 2001 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00013962 History of Changes |
| Health Authority: | United States: Federal Government |
|
Heart Diseases Growth Substances Physiological Effects of Drugs Nervous System Diseases Ergocalciferols Chromosome Disorders Bone Density Conservation Agents Pharmacologic Actions Heart Valve Diseases Mental Retardation Vitamin D |
Williams Syndrome Genetic Diseases, Inborn Vitamins Aortic Stenosis, Supravalvular Neurologic Manifestations Cardiovascular Diseases Micronutrients Aortic Valve Stenosis Congenital Abnormalities Neurobehavioral Manifestations |